SL Science Holding LtdSLBT

NasdaqHealthcareBiological Products, (No Diagnostic Substances)

Price (close)

$1.56

Market cap

$874.8M

P/E

—

Revenue (FY)

—

Net income

—

Dividend yield

—

1-year total return

-84.9%

Net margin

—

Revenue growth

—

Debt / equity

—

What SL Science Holding Ltd does.

SL Science Holding Limited is a holding company with no substantive business operations of its own, and conducts its business activities

through its subsidiary, SL Bio. Unless the context otherwise requires, all references in this section to the “Company,” “SLBT,”

company specialized in developing innovative cellular and gene therapies. Established with a commitment to advancing regenerative medicine